Resmed earnings were $1.3B for the trailing 12 months ending Mar 31, 2025, with 37.1% growth year over year. The latest RMD earnings report on Mar 31, 2025 announced Q1 2025 earnings of $365.0M, up 5.9% from last quarter. For the last reported fiscal year 2024 ending Jun 30, 2024, RMD reported annual earnings of $1.0B, with 13.7% growth. The next RMD earnings date is Jul 31, 2025.
RMD past earnings growth
How has RMD's earnings growth performed historically?
On RMD's earnings call on Invalid Date, Resmed (NYSE: RMD) reported Q1 2025 earnings per share (EPS) of $2.49, up 22.06% year over year. Total RMD earnings for the quarter were $365.04 million. In the same quarter last year, Resmed's earnings per share (EPS) was $2.04.
The next RMD earnings call is Invalid Date. Add RMD to your watchlist to be reminded of Resmed's next earnings date.
Is Resmed profitable or losing money?
As of the last Resmed earnings report, Resmed is currently profitable. Resmed's net profit (also called net income) for the twelve months ending Mar 31, 2025 was $1.31 billion, a 37.03% increase year over year.
What was RMD's earnings growth in the past year?
As of Resmed's earnings date in Invalid Date, Resmed's earnings has grown 37.12% year over year. This is 20.7 percentage points higher than the US Medical Instruments & Supplies industry earnings growth rate of 16.42%. RMD earnings in the past year totalled $1.31 billion.
What are Resmed's earnings expectations?
The current EPS estimate for Resmed's earnings report in Invalid Date is $2.48.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.